Neuroscientific (ASX:NSB) is an innovative biotechnology company advancing novel technologies to treat immune-mediated inflammatory diseases. Our research specialises in mesenchymal stem cells (MSCs) - adult stem cells with unique properties to reduce inflammation, repair damaged tissue, and support the body’s natural immune response.